CBLL · CIK 0001861107 · FY2025 live · 2025-12-31
Ceribell, Inc.
View as
Model
Classic Z
FY2025
1.22
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
48.36
0–100 · Classic Z tape · not a PD
Book standing
50
Year change
—
Market PD
—
O-score
44
Events on this name
Same published rows as Today. Not a live recompute.
MARKET PD UNAVAILABLE
watch · 41
- mertonPd: — → —
1.22
Z″ 3.97
Score 1.22 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.861.2 × = 1.03X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−1.131.4 × = −1.58X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.303.3 × = −0.98X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
3.840.6 × = 2.30X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.451 × = 0.45
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Ceribell, Inc. is on classic Z at 1.22 (distress) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print; retained earnings / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 70th percentile in Healthcare.
- ZOMDFDistressZomedica Corp.1.22
- KIDSDistressORTHOPEDIATRICS CORP1.23
- CBIODistressCRESCENT BIOPHARMA, INC.1.22
- RLAYDistressRelay Therapeutics, Inc.1.21
- RPRXDistressRoyalty Pharma plc1.19
- LLYDistressELI LILLY & Co1.29
- INDVDistressIndivior Pharmaceuticals, Inc.1.16
- AMRXDistressAmneal Pharmaceuticals, Inc.1.30
KPI widgets
Current assets
$187M
Total assets
$196M
Current liabilities
$19M
Total liabilities
$40M
Working capital
$168M
Retained earnings
−$220M
EBIT
−$58M
Total sales
$89M
Book equity
$155M
Accession 0001193125-26-067238. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.